‌

US Patent 12122765 Methods and intermediates for preparing therapeutic compounds

Patent 12122765 was granted and assigned to Gilead Sciences on October, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Gilead Sciences

0

Current Assignee

Gilead Sciences

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Scott Alan Wolckenhauer0

Anna Michelle Wagner0

Date of Patent

October 22, 2024

0

Patent Application Number

182058770

Date Filed

June 5, 2023

0

Patent Citations

US Patent 8748412 Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulators

0

US Patent 8754065 Tenofovir alafenamide hemifumarate

0

US Patent 8835488 Opioid receptor ligands and methods of using and making same

0

US Patent 9012441 Therapeutic compounds

0

US Patent 9050344 Therapeutic compounds

0

US Patent 9216996 Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepines and methods for treating viral infections

0

US Patent 9220710 Therapeutic compounds

0

US Patent 9540343 Compounds for the treatment of HIV

0

...

Patent Primary Examiner

Charanjit Aulakh

0

CPC Code

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12122765 Methods and intermediates for preparing therapeutic compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.